1. Introduction {#sec0005}
===============

After stroke, approximately 60-- 80% of patients have upper limb motor deficits ([@r15]; [@r28]) that can persist in 30-- 66% of cases into the chronic stage ([@r27]). Upper limb recovery is important for minimizing long-term disability and improving the quality of life. Most rehabilitation interventions focus on facilitating recovery through motor learning principles ([@r26]). Motor learning involves perception, cognition and action processes described as the search for a task solution that emerges from an interaction of the individual with the desired action and the environment ([@r35]).

Learning engages cognitive processes such as attention, memory and executive functioning, all of which may be affected by stroke ([@r22]). Research is increasingly focusing on the investigation of the impact of the manipulation of motor learning principles on upper limb motor improvement ([@r8]). In studies of motor recovery, however, cognitive and motor elements have often been considered as separate systems. Indeed, most studies investigating the effectiveness of post-stroke upper limb rehabilitation interventions exclude individuals with stroke who have cognitive deficits. On the other hand, relationships between cognitive and motor deficits are increasingly being identified ([@r1]) at body structure and function (impairment), activity limitation and participation levels of the International Classification of Function (ICF; World Health Organization, n.d.). Cognitive dysfunction is recognized as influencing rehabilitation outcomes as well as predicting functional independence and participation after stroke ([@r39]; [@r20]). For example, individuals with stroke who had more impaired cognition performed worse on the Functional Independence Measure (FIM) after rehabilitation compared to those with less cognitive impairment ([@r38]). Rehabilitation outcomes identified using generic activity scales including the FIM and Barthel Index (BI), do not discriminate between use of the more affected vs. the less affected limbs nor do they specifically identify impairment and activity limitations such as endpoint performance variables and quality of movement of the affected limbs ([@r29]). Describing motor behavior at these two levels provides information about the movement of the endpoint (e.g., movement speed, precision and smoothness) and the movement patterns used to displace the endpoint (e.g. ranges of joint motion and/or coordination; [@r8]). Thus, generic scales are poor indicators of motor recovery of the upper limb at these levels.

Evidence is emerging about the specific relationship between cognitive deficits and upper limb improvement at both impairment and activity levels of the ICF. Information about these relationships is important to design personalized interventions more tailored to the individual in order to maximize upper limb recovery. The aim of this meta-analysis was to examine the evidence on the strength of the association between cognitive deficits and improvements in upper limb motor impairment and activity limitation in individuals with stroke.

2. Methods {#sec0010}
==========

2.1. Search strategy {#sec0015}
--------------------

A structured review of the English language literature covering five databases: Pubmed, Ovid MEDLINE, CINHAL, Embase, and ISI Web of Science was performed by AAM. Various combinations of MeSH terms and key words including; stroke, cerebrovascular accident, upper limb, cognit\*, attention, memory and executive function were used. Reference lists of retrieved studies were searched to identify other pertinent articles.

2.2. Selection criteria {#sec0020}
-----------------------

No date restrictions were imposed, yielding potential articles up to September 2014. Peer-reviewed articles reporting original research were included if 1) baseline cognition scores were provided; 2) arm motor impairment and/or activity limitation measures were included as study outcomes; 3) repetitive movement or more comprehensive motor rehabilitation interventions were delivered; 4) statistical associations between baseline cognition and motor outcome scores were done or could be derived from the data.

Studies were excluded if hemispatial neglect, a visuoperceptual disorder, agnosia or apraxia were included as cognitive deficits, since they are not due to purely cognitive etiologies ([@r16]; [@r40]). Studies involving dual-task paradigms were excluded since improvement in dual-task performance after training could be due to changes in cognitive function without actual motor learning. Cross-sectional studies not investigating motor learning were also excluded, since it was not possible to identify changes due to motor learning from a single time-point measure. Furthermore, studies that measured improvement on motor subscales of generic functional tests (FIM and BI) were excluded since they are not specific to the upper limb and improved scores could reflect increased compensation with the less affected extremity ([@r29]) and/or improvement in lower limb ability.

2.3. Study quality assessment {#sec0025}
-----------------------------

All retrieved studies were reviewed by AAM and SKS and conflicts were resolved by MFL. Depending on the study design, studies were rated for soundness of methodology and reporting using valid and reliable quality of evidence scales: the 10-point PEDro Scale for Randomized Control Trials (RCT; [@r32]; [@r13]) and the 27-item Downs and Black Checklist for non-randomized studies ([@r11]). The 12-item Quality Assessment Tool for Before-After (Pre-Post) Studies with no Control Group ([@r25]) was also used. Scores were normalized on each scale. Studies scoring ≥60% , 40-- 59% or \<39% were rated as good, fair and poor respectively ([@r13]).

2.4. Meta-analyses {#sec0030}
------------------

Meta-analyses (MedCalc, v14.8.1, Ostend, Belgium) examined strengths of associations between cognitive deficits and improvements in arm motor impairment and activity limitation. When an article reported more than one intervention, each intervention was entered as a separate study. For studies that used more than one cognitive measure and/motor outcome, the maximally correlated measures were used. Pooled association effects were calculated with weighted summary correlation coefficients (fixed effects model, z scores; [@r19]). Heterogeneity was assessed using Cochran's Q and I^2^ for random effects ([@r10]). Studies were considered heterogeneous if I^2^\>50% ([@r21]).

3. Results {#sec0035}
==========

3.1. Search results {#sec0040}
-------------------

A total of 202 articles were retrieved from Pubmed. Six articles were included, 5 of which met our selection criteria and one additional article was retrieved from the reference lists of the included articles. No additional articles were retrieved from the other databases ([Fig. 1](#rnn-33-3-rnn150510-g001){ref-type="fig"}). Among the six included studies, there was one RCT ([@r7]), one non-randomized control trial ([@r44]), three pre-post studies ([@r4]; [@r3]; [@r41]) and one cross-sectional study ([@r9]), involving a total of 128 participants. Stroke chronicity varied from 3 weeks to 2.3 years ([Table 1](#rnn-33-3-rnn150510-t001){ref-type="table"}). The quality of the studies ranged from fair to good ([Table 2](#rnn-33-3-rnn150510-t002){ref-type="table"}).

3.2. Measures of cognition {#sec0045}
--------------------------

All included studies used valid and reliable neuropsychological tests ([Table 3](#rnn-33-3-rnn150510-t003){ref-type="table"}). All but one study ([@r3]) examined two or more cognitive domains -- attention, memory and executive function (information processing speed, planning abilities, cognitive flexibility) - via composite or individual domain scores ([Table 3](#rnn-33-3-rnn150510-t003){ref-type="table"}). One study (Barecca et al., 1999) examined executive function only. Studies used raw (Boe et al., 2014; Barreca et al., 1999), ranked ([@r9]) or adjusted ([@r7]; [@r4]; [@r41]) scores for statistical analyses. The study samples were all heterogeneous in terms of severity of cognitive deficits except for one ([@r41]) that included a mildly affected stroke group. Seven of the ten subjects included in another study had average/above average executive function although they differed widely in attention scores ([@r9]).

3.3. Measures of arm motor improvement {#sec0050}
--------------------------------------

All studies used different clinical outcomes to measure baseline motor ability. One study ([@r41]) only included subjects with mild arm motor deficits, two only included subjects with mild/moderate arm deficits ([@r44]; [@r4]) while the other three had heterogeneous samples including subjects with more severe impairments ([@r7]; [@r3]; [@r9]).

Motor improvement occurred in participants of all studies ([Table 3](#rnn-33-3-rnn150510-t003){ref-type="table"}). Two studies ([@r7]; [@r9]) assessed motor improvement using kinematically derived measures, while the others used only clinical measures to describe improvement ([Table 1](#rnn-33-3-rnn150510-t001){ref-type="table"}).

3.4. Type of intervention {#sec0055}
-------------------------

Each study included different interventions or tasks. In two studies, participants practiced single tasks such as reaching or rapid elbow flexion ([@r7]; [@r9]), and in the others, they participated in outpatient rehabilitation ([@r3]), programs involving Arm Ability Training (AAT; [@r41]), repetitive task practice ([@r44]), or Constraint Induced Movement Therapy (CIMT; [@r4]) all of which likely involved multiple upper limb tasks. While principles of motor learning such as repetition were used in most studies ([@r7]; [@r9]; [@r41]; [@r44]; [@r4]), only two ([@r7]; [@r9]) specified the type of feedback used and the manner in which it was delivered. The duration of the interventions varied widely among the studies from one day to 8 weeks and training intensity varied from 30 minutes to 6 hours per session([Table 1](#rnn-33-3-rnn150510-t001){ref-type="table"}).

3.5. Relationship between cognition and improvement of motor impairment {#sec0060}
-----------------------------------------------------------------------

Of the six studies, two ([@r3]; [@r9]) demonstrated a relationship between cognition and motor improvement, three found motor improvement to be independent of pre-stroke cognitive levels ([@r44]; [@r4]; [@r41]) and one ([@r7]) showed a differential effect based on the type of intervention ([Table 2](#rnn-33-3-rnn150510-t002){ref-type="table"}). In order to determine the extent to which cognition and motor improvement are related, we performed a series of meta-analyses. The first analysis combined all studies irrespective of the cognitive domain assessed and the motor outcome used ([Fig. 2](#rnn-33-3-rnn150510-g002){ref-type="fig"}, [Table 4](#rnn-33-3-rnn150510-t004){ref-type="table"}). A positive correlation of moderate strength was found between cognition and arm motor improvement (*r* = 0.43; CI: 0.09-- 0.68; *p* = 0.014).

Separate meta-analyses revealed a moderately strong association between executive function and motor improvement (*r* = 0.48; CI: 0.26-- 0.65; *p* \<  0.001), a weak positive correlation between attention and motor improvement (*r* = 0.25; CI: 0.04-- 0.45; *p* = 0.023) and no correlation between memory and motor improvement (*r* = 0.42; CI: −0.16-- 0.79; *p* = 0.14; [Fig. 3](#rnn-33-3-rnn150510-g003){ref-type="fig"}, [Table 5](#rnn-33-3-rnn150510-t005){ref-type="table"})

Additional meta-analyses showed stronger associations between cognition and motor improvement when kinematic motor outcomes are used rather than clinical scales (*r* = 0.72; CI: 0.49-- 0.85; *p* \<  0.001 and *r* = 0.13, CI: −0.21-- 0.45; *p* = 0.45 respectively, [Table 4](#rnn-33-3-rnn150510-t004){ref-type="table"}).

4. Discussion {#sec0065}
=============

The evidence on the strength of the association between cognitive deficits and improvements in upper limb motor impairment and activity limitations in patients who have sustained a stroke was examined. Our meta-analysis revealed, for the first time, a moderate association (*r* = 0.43; CI: 0.09-- 0.68) between cognition and overall arm motor improvement ([Fig. 2](#rnn-33-3-rnn150510-g002){ref-type="fig"}) from a total of 6 moderate to high quality studies.

4.1. Association between individual cognitive domains and arm motor improvement {#sec0070}
-------------------------------------------------------------------------------

We found that deficits in executive functioning affect motor improvement to a greater extent than deficits in either attention or memory ([Fig. 3](#rnn-33-3-rnn150510-g003){ref-type="fig"}, [Table 5](#rnn-33-3-rnn150510-t005){ref-type="table"}). This is consistent with findings from [@r30], in which levels of executive functioning were more strongly correlated with learning arm movement patterns than other cognitive domains. Executive functions include task initiation, problem-solving, perseveration, abstract reasoning, planning, organization, mental flexibility and information processing ([@r31]). Executive function is involved in appropriately modifying behaviour and adapting movement to changing environmental conditions when new information is available ([@r12]). Thus, it may be more important than attention and memory for deriving benefit from therapies that use problem solving approaches such as CIMT ([@r4]), error correction through evaluation of results of a previous trial ([@r9]) and adapting movement based on external cues ([@r7]).

Our results show a weak association between attention and improvements in arm impairments and activity limitations and no association between memory and motor improvement. This is in contrast to previous research demonstrating stronger associations between attention and improvement in arm activity scores ([@r5]; [@r42]; [@r23]) and between memory and motor rehabilitation outcomes ([@r34]). Dissimilarities in the chronicity of the stroke population in previous studies and those included in the present meta-analysis, may account for the differences. Studies that found strong associations between attention/memory and motor improvement ([@r42]; [@r23]; [@r34]) examined individuals with more acute stroke than those included in this review. The nature of the association between different cognitive domains and motor recovery may not be the same in the acute and chronic phases of stroke([@r36]; [@r45]; [@r2]). Indeed, [@r36], [@r45] and [@r2] found that while attention and memory impairments are common in the acute state after stroke, deficits in executive function are more prevalent in the chronic stage.

4.2. Influence of severity of motor and cognitive deficits {#sec0075}
----------------------------------------------------------

The severities of motor and cognitive deficits in individuals with stroke have previously been identified as strong predictors of motor recovery ([@r1]; [@r39]; [@r20]). Our results may have been influenced by differences in the levels of cognitive and/or motor impairment of the participants between studies. For example, we found that studies that included patients with more severe motor deficits, found stronger correlations ([@r7]; [@r3]; [@r9]) than those ([@r44]; [@r4]; [@r41]) that included participants with only mild to moderate motor deficits. We also found that two of the three studies ([@r4]; [@r41]) that identified no association between cognition and motor improvement included participants with only mild cognitive impairment. The third study ([@r44]) used a composite score to describe cognitive function. It is possible that different results may have been obtained if individual domain scores had been used. Therefore, our results are suggestive of different relationships between cognition and motor improvements depending upon the severity of motor and cognitive impairments.

4.3. Impact of outcomes used to measure motor improvement {#sec0080}
---------------------------------------------------------

In previous work examining associations between cognition and motor recovery, rather than characterizing motor recovery at the level of impairment, some studies assessed functional recovery using generic measures, such as motor subscales of the FIM or the BI. Results from these studies show weak ([@r14]) to moderately positive associations ([@r5]; [@r33]) between cognition and motor recovery similar to those obtained in our meta-analyses. However, generic outcomes are not specific to the recovery of motor activities of the more affected side of the body, do not discriminate between motor performance and quality of movement variables and combine improvements of the upper and lower limbs. Therefore, scores obtained from these measures are not helpful when designing targeted motor impairment or activity-based treatment interventions.

Motor improvement at the impairment or activity level can be assessed with both clinical and kinematic outcome measures. Our meta-analysis showed a stronger association between cognition and motor recovery when more sensitive kinematic measures were used ([Table 4](#rnn-33-3-rnn150510-t004){ref-type="table"}). Only two studies included in our review ([@r7]; [@r9]) examined the relationship between cognition and arm recovery using kinematic outcomes. Both studies found positive associations between motor performance and executive function ([@r7]; [@r9]) and memory ([@r7]). Improvements in motor performance outcomes can indicate actual behavioural recovery or an increased use of compensatory movements ([@r29]). Movement quality outcomes were not measured in any of the studies included in our review. These outcomes have stronger associations with cognitive impairments ([@r30]) and are more sensitive to improvements in motor impairment than clinical scales ([@r46]). Therefore, it is suggested that kinematic outcomes should be included as motor impairment measures in future studies to obtain a better understanding of the relationship between motor recovery and cognitive deficits.

4.4. Clinical implications {#sec0085}
--------------------------

Rehabilitation therapies for the upper limb in individuals who have sustained a stroke are designed to promote motor learning. It has been suggested that learning is enhanced by optimally challenging the individual through manipulation of the task difficulty according to the motor skill level of the performer, and their cognitive (information processing ability) capacity ([@r17]). Learning is also related to performance or feedback-related intrinsic and extrinsic sensory information obtained during task performance ([@r6]; [@r47]) which also depends on task complexity and cognitive processing. Our results suggest that clinicians should select appropriate motor learning approaches based on the characteristics of the individual and the specific motor outcomes to be improved. For example, one study ([@r7]) found no correlation between cognitive scores and motor improvement in a group of stroke subjects receiving KR feedback, but found a strong association between the two in a group receiving KP feedback. In the KP group, improvements in movement smoothness and precision were related to better memory, mental flexibility and planning abilities. It is possible that executive function and memory are more involved in processing information about moving and adapting movement behaviour. Thus, KP feedback should be prescribed with caution for individuals with specific cognitive deficits.

Cognitive impairments may affect the ability of the patient to understand and remember task instructions, plan and initiate self-directed activities and solve problems. Preliminary studies have suggested that individualizing treatment strategies based on individual cognitive and motor deficits may improve treatment effectiveness. For example, an RCT comparing the effectiveness of Neurodevelopmental Therapy (NDT, without cognitive rehabilitation) and Problem Oriented Willed Movement therapy (POWM, combined motor and cognitive rehabilitation) reported better motor outcomes in the POWM group compared to the NDT group ([@r48]).

4.5. Future directions {#sec0090}
----------------------

There is mounting interest in understanding the relationship between cognition and motor recovery. Evidence that treatment effectiveness may improve by integrating cognitive and motor rehabilitation is beginning to surface. However, additional information about optimal methods of treatment delivery is required to design more targeted therapies. For example, is discovery learning (trial and error learning) or guiding the patient towards a particular motor solution (errorless learning) more effective in individuals with stroke who have cognitive disorders? Evidence suggests that trial and error learning results in better skill retention than errorless learning approaches for individuals without memory deficits ([@r43]), but errorless learning may be more effective for retention of information in people with cognitive disorders ([@r37]; [@r49]). Similarly, questions regarding the differential effects of timing and the mode of feedback delivery (visual/ tactile/ verbal) and efficacy of blocked versus random practice in patients with and without cognitive disorders are yet to be addressed.

4.6. Limitations {#sec0095}
----------------

While this review provides important information about the interaction between cognitive and motor deficits in post-stroke individuals, results of the meta-analysis should be considered preliminary because of the small number of studies, as well as the small number of participants in each study. A limitation of the analysis is the lack of information about whether results may be related to lesion size and site.

5. Conclusion {#sec0100}
=============

Cognitive status affects therapy outcome but more research is needed to identify how severity of deficits, chronicity and intervention delivery impact this association. Further research in this area is essential in order to provide more personalized therapies.
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###### 

Characteristics of studies included in the review

  ----------------------
  Study\
  name
  ----------------------
  Barreca et al. 1999

  Dancause et al. 2002

  Platz &Denzler 2002

  Cirstea et al. 2006

  Skidmore et al. 2012

  Boe et al. 2014
  ----------------------

Att- Attention; Mem-Memory; Exec Funct-Executive Function; RCT-Randomized Control Trial; S-stroke; C-healthy control; TBI-Traumatic Brain Injury; KP-Knowledge of performance; KR-Knowledge of results; CI-cognitive impairments; UL-- upper limb; UEFT-Upper Extremity Function Test; TEMPA-Arm Function Test; FM-Fugl-Meyer (upper extremity subsacale); ARAT-Action Research Arm Test; WMFT-Wolf Motor Function Test; ✓-Tested; ×-Not Tested.

###### 

Study quality determined by PEDro Scale, Downs and Black Checklist or Quality Assessment Tool for Before-After (Pre-Post) Studies with no Control Group based on percentage scoring ≥60% , 40-- 59% or \<39% (Good, Fair, Poor, respectively). The presence (YES) or absence (NO) of an association between cognitive and motor improvement scores is listed in column 4

  ----------------------------------------------------------------
  Study\                    Score     Quality of\   Association\
  name                                   study       present/not
  ---------------------- ----------- ------------- ---------------
  Barreca et al. 1999     7/11 (12)      Fair            Yes

  Dancause et al. 2002       --           --             Yes

  Platz &Denzler 2002     7/11 (12)      Fair            No\
                                                    KP group- Yes

  Cirstea et al. 2006       8/10         Good      

                                                    KR group- No

  Skidmore et al. 2012      21/27        Good            No

  Boe et al. 2014         8/11 (12)      Good            No
  ----------------------------------------------------------------

###### 

Detailed methodology about cognitive and motor outcome measures used and results of studies included in the review

  -------------
  Author
  -------------
  Barreca\
  et al. 1999

  Dancause\
  et al. 2002

  Platz &\
    Denzler\
    2002

  Cirstea\
    et al.\
    2006

  Skidmore\
    et al.\
    2012

  Boe\
    et al.\
    2014
  -------------

ROCFT- Rey-Osterrieth Complex Figure Test; WMSS- Wechsler Memory Scale Stories; WCST- Wisconsin Card Sorting Test; FM- Fugl-Meyer Assessment; CM- Chedoke McMaster; WAIS-R- Wechsler Adult Intelligence Scale-Revised; IQ- Intelligence Quotient; KR- knowledge of results; KP- knowledge of performance; Movt- movement; RAVLT- Rey Auditory Verbal Learning Test. ROCFT- Rey-Osterrieth Complex Figure Test.

###### 

Results of the meta-analysis examining the correlation between cognition and arm motor improvement

  Study                                      Correlation       95%         z       *p*
  -------------------------- -------------- ------------- -------------- ------ ---------
  Barreca et al. 1999              16           0.64       0.21-- 0.86          
  Dancause et al. 2002             10           0.45       −0.25-- 0.84         
  Platz &Denzler 2002              33           0.15       −0.20-- 0.47         
  Cirstea et al. 2006 (KP)         14           0.87       0.63-- 0.96          
  Cirstea et al. 2006 (KR)         14           0.63       0.14-- 0.87          
  Skidmore et al. 2012             20           −0.20      −0.59-- 0.26         
  Boe et al. 2014                  21           0.19       −0.26-- 0.58         
  Total (fixed effects)           128           0.36       0.19-- 0.51    3.92   \<0.001
  Total (random effects)          128           0.43       0.09-- 0.68    2.46    0.014
  *Test for heterogeneity*                                                      
  Q                              21.31                                          
  DF                               6                                            
  Significance                *P* = 0.0016                                      
  I^2^                           71.86%                                         

n-Sample size; CI-Confidence interval; Q-Cochran's Q; DF-degrees of freedom, I^2^ = 100% × (Q-df)/Q; KP-Knowledge of performance; KR-Knowledge of results.

###### 

Results of meta-analyses of studies that examined the correlation between arm motor improvement and (A) executive function, (B) attention and (C) memory

  Study                                                                                              *n*   Correlation coefficient      95% CI        z       *p*
  ------------------------------------------------------------------------------------------------- ----- ------------------------- -------------- ------- ---------
  A. Executive Function                                                                                                                                    
  Barreca et al. 1999                                                                                16             0.64             0.21-- 0.86           
  Dancause et al. 2002                                                                               10             0.45             −0.25-- 0.84          
  Cirstea et al. (KP) 2006                                                                           14             0.64             0.17-- 0.88           
  Cirstea et al. (KR) 2006                                                                           14             0.63             0.14-- 0.87           
  Boe et al. 2014                                                                                    21             0.07             −0.37-- 0.49          
  Total (fixed effects)                                                                              75             0.48             0.26-- 0.65    3.996   \<0.001
  Total (random effects)                                                                             75             0.49             0.23-- 0.68    3.469    0.001
  Heterogeneity- Q = 5.53; DF = 4; *P* = 0.24; I^2^ = 27.67% ; 95% CI for I^2^ = 0-- 71.57                                                                 
  B. Attention                                                                                                                                             
  Dancause et al. 2002                                                                               10             −0.03            −0.65-- 0.61          
  Platz and Denzler 2002                                                                             33             0.15             −0.20-- 0.47          
  Cirstea et al. 2006 (KP)                                                                           14             0.38             −0.19-- 0.76          
  Cirstea et al. 2006 (KR)                                                                           14             0.63             0.14-- 0.87           
  Boe et al. 2014                                                                                    21             0.18             −0.27-- 0.57          
  Total (fixed effects)                                                                              92             0.25             0.037-- 0.45   2.281    0.023
  Total (random effects)                                                                             92             0.25             0.037-- 0.45   2.281    0.023
  Heterogeneity- Q = 3.72; DF = 4; *P* = 0.45; I^2^ = 0% ; 95% CI for I^2^ = 0-- 78.94                                                                     
  C. Memory                                                                                                                                                
  Platz and Denzler 2002                                                                             33             −0.15            −0.47-- 0.20          
  Cirstea et al. 2006 (KP)                                                                           14             0.87             0.63-- 0.96           
  Cirstea et al. 2006 (KR)                                                                           14             0.50             −0.04-- 0.82          
  Boe et al. 2014                                                                                    21             0.19             −0.26-- 0.58          
  Total (fixed effects)                                                                              82             0.27             0.046-- 0.47   2.343    0.019
  Total (random effects)                                                                             82             0.42             −0.16-- 0.79   1.450    0.147
  Heterogeneity- Q = 18.62; DF = 3; *P* = 0.0003; I^2^ = 83.89% ; 95% CI for I^2^ = 59.36-- 93.62                                                          

n- Sample size; CI- Confidence interval; p- Level of significance; Q- Cochran's Q; DF- degrees of freedom, I^2^ = 100% × (Q-df)/Q; KP- Knowledge of performance; KR- Knowledge of results.

###### 

Results of meta-analyses for association between cognition and arm motor improvement scores based on the motor outcome measures used

  Study                                                                                            *n*   Correlation coefficient      95% CI        z       *p*
  ----------------------------------------------------------------------------------------------- ----- ------------------------- -------------- ------- ---------
  A. Kinemetics                                                                                                                                          
  Dancause et al. 2002                                                                             10             0.45             −0.25-- 0.84          
  Cirstea et al. 2006 (KP)                                                                         14             0.87             0.63-- 0.96           
  Cirstea et al. 2006 (KR)                                                                         14             0.63             0.14-- 0.87           
  Total (fixed effects)                                                                            38             0.72             0.49-- 0.85    4.851   \<0.001
  Total (random effects)                                                                           38             0.71             0.37-- 0.88    3.513   \<0.001
  Heterogeneity- Q = 3.58; DF = 2; *P* = 0.17; I^2^ = 44.08% ; 95% CI for I^2^ = 0−83.30                                                                 
  B. Clinical Scales                                                                                                                                     
  Barreca et al. 1999                                                                              16             0.64             0.21-- 0.86           
  Platz and Denzler 2002                                                                           33             0.15             −0.20-- 0.47          
  Cirstea et al. 2006 (KP)                                                                         14             0.47             −0.08-- 0.80          
  Cirstea et al. 2006 (KR)                                                                         14             −0.54            −0.83-- 0.02          
  Skidmore et al. 2012                                                                             20             −0.20            −0.59-- 0.26          
  Boe et al. 2014                                                                                  21             0.19             −0.26-- 0.58          
  Total (fixed effects)                                                                            118            0.13             −0.06-- 0.32   1.335    0.182
  Total (random effects)                                                                           118            0.13             −0.21-- 0.45   0.763    0.445
  Heterogeneity- Q = 14.71; DF = 5; *P* = 0.01; I^2^ = 66.02% ; 95% CI for I^2^ = 18.69-- 85.80                                                          

n- Sample size; CI- Confidence interval; p- Level of significance; Q- Cochran's Q; DF- degrees of freedom; I^2^ = 100% × (Q-df)/Q; KP- Knowledge of performance; KR- Knowledge of results.
